In addition to impairing the tumor-suppressing roles of PTEN, the ablated metabolic functions of PAPSS2 have been linked to cancer reoccurrences, which emphasize the combined impact of collateral gene deletions in cancer cells (Ibeawuchi et al, 2015; Poluri & Audet-Walsh, 2018). This evidence concerns the gene PAPSS2 and cancer.